GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (FRA:TGK) » Definitions » Cyclically Adjusted Price-to-FCF

Precipio (FRA:TGK) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to . Start your Free Trial

What is Precipio Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Precipio Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Precipio's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precipio Cyclically Adjusted Price-to-FCF Chart

Precipio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Precipio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Precipio's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Precipio's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precipio's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Precipio's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Precipio's Cyclically Adjusted Price-to-FCF falls into.



Precipio Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Precipio's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Precipio's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.445/131.7762*131.7762
=-0.445

Current CPI (Mar. 2024) = 131.7762.

Precipio Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -2,544.000 100.560 -3,333.734
201409 -3,076.000 100.428 -4,036.169
201412 -2,029.000 99.070 -2,698.846
201503 -3,255.000 99.621 -4,305.629
201506 -2,391.000 100.684 -3,129.367
201509 -1,564.000 100.392 -2,052.942
201512 -1,315.500 99.792 -1,737.122
201603 -872.500 100.470 -1,144.364
201606 1,365.000 101.688 1,768.885
201609 -225.000 101.861 -291.079
201612 -301.000 101.863 -389.393
201703 -305.000 102.862 -390.734
201706 -254.000 103.349 -323.865
201709 -120.280 104.136 -152.206
201712 -54.912 104.011 -69.570
201803 -22.214 105.290 -27.802
201806 -31.072 106.317 -38.513
201809 -13.494 106.507 -16.696
201812 -17.616 105.998 -21.900
201903 -9.686 107.251 -11.901
201906 -9.491 108.070 -11.573
201909 -6.269 108.329 -7.626
201912 -5.177 108.420 -6.292
202003 -3.484 108.902 -4.216
202006 -3.148 108.767 -3.814
202009 -2.629 109.815 -3.155
202012 -1.386 109.897 -1.662
202103 -1.358 111.754 -1.601
202106 -1.490 114.631 -1.713
202109 -1.818 115.734 -2.070
202112 -1.167 117.630 -1.307
202203 -1.875 121.301 -2.037
202206 -1.452 125.017 -1.531
202209 -2.094 125.227 -2.204
202212 -1.284 125.222 -1.351
202303 -1.285 127.348 -1.330
202306 -0.935 128.729 -0.957
202309 -0.618 129.860 -0.627
202312 0.043 129.419 0.044
202403 -0.445 131.776 -0.445

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precipio  (FRA:TGK) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Precipio Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Precipio's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Precipio (FRA:TGK) Business Description

Traded in Other Exchanges
Address
4 Science Park, New Haven, CT, USA, 06511
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.

Precipio (FRA:TGK) Headlines

No Headlines